AVIR
Price
$3.48
Change
+$0.04 (+1.16%)
Updated
Nov 8, 03:11 PM (EDT)
116 days until earnings call
MGTX
Price
$6.95
Change
+$0.22 (+3.27%)
Updated
Nov 8, 03:30 PM (EDT)
124 days until earnings call
Ad is loading...

AVIR vs MGTX

Header iconAVIR vs MGTX Comparison
Open Charts AVIR vs MGTXBanner chart's image
Atea Pharmaceuticals
Price$3.48
Change+$0.04 (+1.16%)
Volume$831
CapitalizationN/A
MeiraGTx Holdings
Price$6.95
Change+$0.22 (+3.27%)
Volume$500
CapitalizationN/A
View a ticker or compare two or three
AVIR vs MGTX Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AVIR vs. MGTX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and MGTX is a Buy.

COMPARISON
Comparison
Nov 08, 2024
Stock price -- (AVIR: $3.44 vs. MGTX: $6.73)
Brand notoriety: AVIR and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 148% vs. MGTX: 140%
Market capitalization -- AVIR: $302.23M vs. MGTX: $519.45M
AVIR [@Biotechnology] is valued at $302.23M. MGTX’s [@Biotechnology] market capitalization is $519.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVIR and MGTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 6 bullish TA indicator(s).

  • AVIR’s TA Score: 4 bullish, 3 bearish.
  • MGTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а +6.17% price change this week, while MGTX (@Biotechnology) price change was +21.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +11.55%.

Reported Earning Dates

AVIR is expected to report earnings on Mar 04, 2025.

MGTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+3.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($519M) has a higher market cap than AVIR($302M). AVIR YTD gains are higher at: 12.787 vs. MGTX (-4.131). MGTX has higher annual earnings (EBITDA): -65.93M vs. AVIR (-203.66M). AVIR has more cash in the bank: 502M vs. MGTX (100M). AVIR has less debt than MGTX: AVIR (2.03M) vs MGTX (87.6M). MGTX has higher revenues than AVIR: MGTX (8.12M) vs AVIR (0).
AVIRMGTXAVIR / MGTX
Capitalization302M519M58%
EBITDA-203.66M-65.93M309%
Gain YTD12.787-4.131-310%
P/E RatioN/AN/A-
Revenue08.12M-
Total Cash502M100M502%
Total Debt2.03M87.6M2%
FUNDAMENTALS RATINGS
AVIR vs MGTX: Fundamental Ratings
AVIR
MGTX
OUTLOOK RATING
1..100
6626
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
5436
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (41) in the Biotechnology industry is in the same range as MGTX (59). This means that AVIR’s stock grew similarly to MGTX’s over the last 12 months.

AVIR's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as MGTX (100). This means that AVIR’s stock grew similarly to MGTX’s over the last 12 months.

AVIR's SMR Rating (94) in the Biotechnology industry is in the same range as MGTX (98). This means that AVIR’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as AVIR (54). This means that MGTX’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's P/E Growth Rating (95) in the Biotechnology industry is in the same range as MGTX (100). This means that AVIR’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRMGTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIJCX95.360.70
+0.74%
Fidelity Advisor Consumer Staples Z
MVGLX18.200.11
+0.61%
MFS Low Volatility Global Equity R3
MLNAX24.220.14
+0.58%
Morgan Stanley Instl Glbl Concntr A
WMBLX14.440.01
+0.07%
WesMark Balanced
PBEAX24.64-0.02
-0.08%
PGIM Jennison Value A

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with INZY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-3.91%
INZY - AVIR
49%
Loosely correlated
-3.07%
NTLA - AVIR
47%
Loosely correlated
-0.37%
HEPA - AVIR
47%
Loosely correlated
-0.14%
VIR - AVIR
47%
Loosely correlated
-3.93%
MGTX - AVIR
47%
Loosely correlated
+4.83%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+4.83%
NTLA - MGTX
53%
Loosely correlated
-0.37%
BEAM - MGTX
49%
Loosely correlated
-1.99%
EDIT - MGTX
49%
Loosely correlated
-3.35%
AVIR - MGTX
48%
Loosely correlated
-3.91%
CRSP - MGTX
46%
Loosely correlated
+2.29%
More